Carbon monoxide exposure improves immune function in lupus‐prone mice
- 12 August 2013
- journal article
- Published by Wiley in Immunology
- Vol. 140 (1) , 123-132
Abstract
Summary: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple alterations affecting the normal function of immune cells, such as lymphocytes, dendritic cells (DCs) and monocytes. Although the understanding of autoimmunity has significantly increased, the breakthrough in effective therapies has been modest, making necessary the development of new therapeutic strategies. Here we propose that a new potential target for therapy is haem oxygenase‐1 (HO‐1), an enzyme that catalyses the degradation of the haem group into biliverdin, carbon monoxide (CO) and Fe2+. These products exhibit immunosuppressive and anti‐inflammatory effects, which can contribute to improving tolerance during organ transplantation. Because HO‐1 is highly expressed by immune cells involved in SLE pathogenesis, such as monocytes and DCs, we evaluated whether induction of HO‐1 expression or the administration of CO could ameliorate disease in the FcγRIIb knockout (KO) mouse model for SLE. We found that CO administration decreased the expansion of CD11b+ cells, prevented the decline of regulatory T cells and reduced anti‐histone antibodies observed in untreated FcγRIIb KO mice. Furthermore, CO‐treated animals and HO‐1 induction showed less kidney damage compared with untreated mice. These data suggest that HO‐1 modulation and CO administration can ameliorate autoimmunity and prevent the lupus symptoms shown by FcγRIIb KO mice, highlighting HO‐1 as a potential new target for autoimmune therapy.Keywords
This publication has 53 references indexed in Scilit:
- Carbon monoxide‐treated dendritic cells decrease β1‐integrin induction on CD8+ T cells and protect from type 1 diabetesEuropean Journal of Immunology, 2012
- Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndromeArthritis Research & Therapy, 2011
- Activated Microglia Are Less Vulnerable to Hemin Toxicity due to Nitric Oxide-Dependent Inhibition of JNK and p38 MAPK ActivationThe Journal of Immunology, 2011
- T cells as therapeutic targets in SLENature Reviews Rheumatology, 2010
- Subsets, expansion and activation of myeloid-derived suppressor cellsMedical Microbiology and Immunology, 2010
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosusClinical and Experimental Immunology, 2008
- Pharmacological and Clinical Aspects of Heme OxygenasePharmacological Reviews, 2008
- The TNFα locus is altered in monocytes from patients with systemic lupus erythematosusClinical Immunology, 2007
- Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammationJournal of Clinical Investigation, 2007